Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
CT-P63 是一种针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的广谱中和抗体，其临床前评估和随机 I 期研究
期刊:Emerging Microbes & Infections
影响因子:7.5
doi:10.1080/22221751.2022.2117094
Seo, Ji-Min; Kang, Bobin; Song, Rina; Noh, Hanmi; Kim, Cheolmin; Kim, Jong-In; Kim, Minsoo; Ryu, Dong-Kyun; Lee, Min-Ho; Yang, Jeong-Sun; Kim, Kyung-Chang; Lee, Joo-Yeon; Lee, Hansaem; Woo, Hye-Min; Kim, Jun-Won; Choi, Jung-Ah; Song, Manki; Tomaszewska-Kiecana, Monika; Wołowik, Anna; Kulesza, Agnieszka; Kim, Sunghyun; Ahn, Keumyoung; Jung, Nahyun; Lee, Soo-Young
